Skip to content

Impact of Blood Glucose at the First Trimester of Pregnant Women With Gestational Diabetes on Maternal and Fetal Outcomes and Metabolic Disorders: a Multi-central Prospective Cohort Study

Impact of Blood Glucose at the First Trimester of Pregnant Women With Gestational Diabetes on Maternal and Fetal Outcomes and Metabolic Disorders: a Multi-central Prospective Cohort Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01833559
Enrollment
3
Registered
2013-04-17
Start date
2012-06-30
Completion date
2021-08-31
Last updated
2014-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes

Brief summary

The study is to investigate the impact of blood glucose management at the first trimester of pregnant women with gestational diabetes on the maternal and fetal outcomes and metabolic disorder.

Detailed description

Gestational diabetes(GDM) is the glucose metabolic disorder that first diagnosed during pregnancy. With the development of social economy and the improvement of life, the incidence of GDM increases to a level of 18-20% year by year. High blood glucose has a strong relationship with many adverse maternal and fetal outcomes, but also influences their metabolism including the increase of susceptibility of maternal type 2 diabetes and risk of fetal type 2 diabetes, obesity, coronary heart disease, etc. And therefore, it is significant to screening and managing maternal blood glucose to prevent maternal and fetal adverse outcomes and metabolic disorder. This multi-central prospective cohort study is supposed to study the pregnant women whose fasting blood glucose is slightly increased (between 5.1 mmol/L and 7.0 mmol/L) at the first gestational trimester. The aim of this study is to answer the scientific questions bellow: whether interventions to whom the blood glucose is slightly increased can 1. decrease the incidence of GDM at the second gestational trimester; 2. improve gestational outcomes; 3. decrease the incidence of temporal and distant metabolic disorder of mother and her child. The result will provide scientific evidence for improving the gestational outcomes of GDM women and preventing metabolic disorder of their child during adolescence and adult period.

Interventions

DIETARY_SUPPLEMENTDietary control
DRUGInsulin

If feast blood glucose is over 7.0 mmol/L, the patient will be hospitalized and insulin will be used. The kind of insulin used depends on the need of patients.

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* regular antenatal examination from the first trimester; * accurate left mentoposterior(LMP) verified by ultrasonography(USG); * fasting blood glucose level between 5.1 mmol/L and 7.0 mmol/L.

Exclusion criteria

* younger than 18 years old; * do not give birth in the research centers above; * LMP is undefined and lack of USG during 6-14 gestational weeks; * multiple pregnancy; * non-natural pregnancy(including intrauterine insemination(IUI), in-vitro fertilization and embryo transfer(IVF-ET), etc); * diagnosed DM before pregnancy; * with hepatitis B virus, hepatitis C virus, HIV infection; * taking drugs including glucocorticoid, diuretic, angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker(ACEI/ARB), etc. * complicated with diseases that affect glucose metabolism such as hyperthyroidism and so on.

Design outcomes

Primary

MeasureTime frameDescription
The incidence of GDM at the second gestational trimesterat the second gestational trimester(about 24-28 gestational weeks)The results of oral glucose tolerance test(OGTT) at the second gestational trimester(about 24-28 gestational weeks) which is used to diagnose GDM will be recorded to analysis the incidence of GDM at the second gestational trimester.

Secondary

MeasureTime frameDescription
Gestational outcomesAfter deliveryThe adverse gestational outcomes will be recorded. For example: GDM, preeclampsia,fetal growth restriction(FGR),and so on.

Other

MeasureTime frameDescription
The incidence of temporal and distant metabolic disorder of mother2 months to 1 year after deliveryAfter about 2 months after delivery when mother comes back for postpartum follow-up, some tests will be done, such as regular blood test,blood glucose(fasting and 2 hours after meal), urine regular test and so on.
Child growth measures2 months to 1 year after deliveryChildren's body weight and height will be firstly recorded when their mothers come back for postpartum follow-ups at about 2 months after delivery by asking them or measure their children on the spot if they take their children with them. And the growth measures of children will be recorded for the second time by asking them via telephone at about 1 year after delivery.

Countries

China

Contacts

Primary ContactZilian Wang, Doctor
zilianwang@gmail.com13602885248

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026